한영현, 황보신이, 한옥연, 최혜정, & 민미나. (2019). Safety Assessment of Dapagliflozin in Patients with Type 2 Diabetes. Journal of Korean Society of Health-System Pharmacists, 36(2), 223-231. https://doi.org/10.32429/jkshp.2019.36.2.005
Chicago Style (17th ed.) Citation한영현, 황보신이, 한옥연, 최혜정, and 민미나. "Safety Assessment of Dapagliflozin in Patients with Type 2 Diabetes." Journal of Korean Society of Health-System Pharmacists 36, no. 2 (2019): 223-231. https://doi.org/10.32429/jkshp.2019.36.2.005.
MLA (9th ed.) Citation한영현, et al. "Safety Assessment of Dapagliflozin in Patients with Type 2 Diabetes." Journal of Korean Society of Health-System Pharmacists, vol. 36, no. 2, 2019, pp. 223-231, https://doi.org/10.32429/jkshp.2019.36.2.005.
Warning: These citations may not always be 100% accurate.